J.Safra Asset Management »

Crinetics Pharmaceuticals In shares owned by J.Safra Asset Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by J.Safra Asset Management from 13F filings

Historical chart of J.Safra Asset Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by J.Safra Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by J.Safra Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.0k 96 41.65
2025-06-30 $2.6k 92 28.76
2025-03-31 $2.4k 72 33.54
2024-12-31 $355 7 50.71

More positions owned by J.Safra Asset Management

Invesco Qqq Tr Unit Ser 1 Unit Ser 1 (QQQ)
Select Sector Spdr Trust The Technology Select Sector Spdr Fund Technology (XLK)
Ishares Russell 1000 Growth Etf Rus 1000 Grw Etf (IWF)
Select Sector Spdr Trust The Communication Services Select Sector Spdr Fund Communication (XLC)
Listed Funds Trust Roundhill Magnificent Seven Etf Roundhill Magnif (MAGS)
Select Sector Spdr Trust The Financial Select Sector Spdr Fund Financial (XLF)
Ishares Msci All Country Asia Ex Japan Index Fund Msci Ac Asia Etf (AAXJ)
Vanguard Intl Equity Ind Fd Ftse All World Ex Us Fd Etf Allwrld Ex Us (VEU)
Select Sector Spdr Trust The Energy Select Sector Spdr Fund Energy (XLE)
Select Sector Spdr Trust The Health Care Select Sector Spdr Fund Sbi Healthcare (XLV)
Spdr S&p Dividend Etf S&P Divid EFT (SDY)
Select Sector Spdr Trust The Industrial Select Sector Spdr Fund Indl (XLI)
Spdr S&p 500 Etf Trust Etf Tr Unit (SPY)
Spdr Ser Tr S&p Ins Etf S&p Ins Etf (KIE)
Vaneck Etf Tr Vaneck Semiconductor Etf Semiconductr Etf (SMH)

View all positions for J.Safra Asset Management

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Driehaus Capital Management
Farallon Capital Management
EcoR1 Capital
Henderson Group
Paradigm Biocapital Advisors
Geode Capital Management
State Street Corporation
Jennison Associates
Point72 Asset Management
Siren
Novo A/S

View all funds holding Crinetics Pharmaceuticals In